# Adamis Pharmaceuticals Corporation (ADMP) Source: https://www.quantisnow.com/company/ADMP Generated: 2026-11-08T05:21:00.627Z - Ticker: ADMP - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - Website: adamispharmaceuticals.com ## About Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. ## Latest ADMP news and filings - 2024-02-07 22:19 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-notice-of-delisting-5238483) - 2024-02-06 15:04 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Adamis Pharmaceuticals Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-adamis-pharmaceuticals-corporation-amendment-5232956) - 2024-02-05 14:00 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-bankruptcy-or-receivership-5228864) - 2024-01-31 22:17 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-submission-of-matters-5221137) - 2024-01-23 22:23 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5202406) - 2024-01-23 22:22 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-material-modification-to-5202400) - 2024-01-03 22:03 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5166064) - 2024-01-03 22:02 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-submission-of-matters-5166048) - 2024-01-03 22:00 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-regulation-fd-disclosure-5166021) - 2023-12-21 17:31 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Results of Operations and Financial Condition](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-results-of-operations-5150794) - 2023-12-04 21:47 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5117036) - 2023-12-04 21:45 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-submission-of-matters-5117020) - 2023-11-28 21:41 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-termination-of-a-5106957) - 2023-11-15 21:39 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5088034) - 2023-11-15 21:20 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5087804) - 2023-11-15 21:11 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-submission-of-matters-5087667) - 2023-11-15 21:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-adamis-pharmaceuticals-corporation-5087600) - 2023-11-14 20:51 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-adamis-pharmaceuticals-corporation-5084643) - 2023-11-14 20:57 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-results-of-operations-5084553) - 2023-11-02 20:50 UTC [SEC Form 4] [SEC Form 4 filed by Dorbin John W. Jr.](https://www.quantisnow.com/insight/sec-form-4-filed-by-dorbin-john-w-jr-5056169) - 2023-11-02 20:31 UTC [SEC Form 3] [SEC Form 3 filed by new insider Dorbin John W. Jr.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-dorbin-john-w-5055858) - 2023-10-25 21:18 UTC [SEC Form 4] [SEC Form 4 filed by Cohen Seth](https://www.quantisnow.com/insight/sec-form-4-filed-by-cohen-seth-5038522) - 2023-10-25 21:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Cohen Seth](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-cohen-seth-5038435) - 2023-10-19 21:07 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-entry-into-a-5029365) - 2023-10-17 20:37 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-notice-of-delisting-5024611) - 2023-10-12 20:22 UTC [SEC Form DEFC14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-defc14a-filed-by-adamis-pharmaceuticals-corporation-5017849) - 2023-10-10 10:01 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-notice-of-delisting-5011164) - 2023-10-02 20:49 UTC [SEC Form PREC-14A] [SEC Form PREC14A filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-prec14a-filed-by-adamis-pharmaceuticals-corporation-4998079) - 2023-09-26 12:37 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Adamis Pharmaceuticals Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-adamis-pharmaceuticals-corporation-amendment-4987665) - 2023-09-19 21:17 UTC [SEC Form 4] [SEC Form 4: Versi Ebrahim converted options into 729,200 shares](https://www.quantisnow.com/insight/sec-form-4-versi-ebrahim-converted-options-into-729200-shares-4978892) - 2023-09-08 20:50 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-amendments-to-articles-4962150) - 2023-09-07 17:55 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Thursday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-thursday-4959302) - 2023-09-07 16:02 UTC [Market Insight] [Adamis Pharmaceuticals Changes Name To DMK Pharmaceuticals To Reflect New Strategic Focus; Company's Common Stock Is Expected To Trade Under The New Nasdaq Ticker Symbol "DMK" On Or About September 8, 2023](https://www.quantisnow.com/insight/adamis-pharmaceuticals-changes-name-to-dmk-pharmaceuticals-to-reflect-new-4959076) - 2023-09-05 17:34 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-4952706) - 2023-09-01 20:45 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Shareholder Director Nominations, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-shareholder-director-nominations-4950469) - 2023-08-29 20:30 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-entry-into-a-4943423) - 2023-08-21 21:20 UTC [SEC Form 8-K] [Adamis Pharmaceuticals Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adamis-pharmaceuticals-corporation-filed-sec-form-8-k-results-of-operations-4923607) - 2023-08-21 13:19 UTC [Market Chatter] [Adamis Pharmaceuticals Q2 EPS $(3.40) Up From $(4.20) YoY, Sales $6.95K Down From $39.85K YoY](https://www.quantisnow.com/insight/adamis-pharmaceuticals-q2-eps-340-up-from-420-yoy-sales-4920617) - 2023-08-21 13:15 UTC [Public Offering] [Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/adamis-pharmaceuticals-reports-second-quarter-2023-financial-results-and-provides-4920591) - 2023-08-19 00:42 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Adamis Pharmaceuticals Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-adamis-pharmaceuticals-corporation-4919377) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ADMP - Earnings history: https://www.quantisnow.com/earnings/ADMP - Dividend history: https://www.quantisnow.com/dividends/ADMP - Insider transactions: https://www.quantisnow.com/insiders/ADMP - Options chain: https://www.quantisnow.com/options/ADMP - SEC 8-K filings only: https://www.quantisnow.com/company/ADMP/8-k - RSS and alerts for ADMP: https://www.quantisnow.com/docs/rss-feeds.md